cbdMD, Inc. (YCBD) Investor Relations Documents

cbdMD, Inc. (YCBD) investor relations documents from the company's IR site: 27 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-13Press releasecbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
2026-08-03Press releasecbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived
2026-07-24Press releasecbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access
2026-07-14Press releasecbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
2026-07-09Press releasecbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation
2026-07-07Press releasecbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination
2026-07-01Press releaseOasis Launches Hemp-Derived Mixer
2026-06-25Press releasecbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products
2026-06-16Press releasecbdMD Appoints Wade Brown Chief Marketing Officer
2026-05-14Press releasecbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pa
2026-04-01Press releasecbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
2026-02-17Press releasecbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
2026-02-02Press releasecbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
2026-01-29Press releasecbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
2026-01-14Press releasecbdMD Announces Strategic Acquisition of Bluebird Botanicals
Press releasecbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD's Extensive Saf
Press releasecbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards Agency
Press releasecbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out Target
Press releasecbdMD Becomes the First CBD Company to Earn Prestigious NSF International's Certified for Sport® Certification
Press releasecbdMD Signs Exclusive Agreement to Enter Israeli Market with IM Cannabis Corp.
Press releasecbdMD Therapeutics Releases Research Plan
Press releasecbdMD Reports Fiscal September 30, 2020 Results
Press releasecbdMD Receives NSF International's Good Manufacturing Practice Registration
Press releasecbdMD Reports Preliminary Fourth Quarter and Fiscal 2020 Results
Press releasecbdMD Reports Record Net Sales In Its Third Quarter Fiscal 2020 Results
Press releasecbdMD Reports Second Quarter Fiscal 2020 Results
Press releasecbdMD Reports Record First Quarter Fiscal 2020 Net Sales of $10.14 Million

YCBD overview · YCBD earnings · YCBD financials · YCBD KPIs · YCBD ownership · YCBD peers · YCBD filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.